PAVmed Q2 EPS $(1.19) Beats $(1.45) Estimate, Sales $979.00K Miss $1.20M Estimate
PAVmed Q2 EPS $(1.19) Beats $(1.45) Estimate, Sales $979.00K Miss $1.20M Estimate
pavmed第二季每股收益为$(1.19)，超过了$(1.45)的预估，销售额为$97.9万，低于$120万的预估。
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(1.19) per share which beat the analyst consensus estimate of $(1.45) by 17.93 percent. This is a 43.33 percent increase over losses of $(2.10) per share from the same period last year. The company reported quarterly sales of $979.00 thousand which missed the analyst consensus estimate of $1.20 million by 18.42 percent. This is a 489.76 percent increase over sales of $166.00 thousand the same period last year.
pavmed（纳斯达克：PAVM）报告每股亏损1.19美元，超出分析师的预估1.45美元，增长了17.93％。这比去年同期每股亏损2.10美元增长了43.33％。该公司报告的季度销售额为97.9万美元，比分析师预估的120万美元低了18.42％。这比去年同期销售额16.6万美元增长了489.76％。